Instrument Inactif

Communiqués Evotec SE Other OTC

Actions

EVTCY

US30050E1055

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Evotec announces progress in neuroscience collaboration with Bristol Myers Squibb	12/06	EQ
Evotec : Presence and Voting Results AGM 2024 229.115 KB	11/06	PU
Evotec SE: Results of the Annual General Meeting 2024	10/06	EQ
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	04/06	EQ
Evotec : Aurobac Therapeutics presents its R&D strategy & pipeline and announces new development program with Boehringer Ingelheim	03/06	PU
Evotec : and QIAGEN enter software collaboration for enhanced multi-omics data insights	03/06	PU
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	30/05	EQ
Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration to identify novel therapeutic targets in obesity and metabolic diseases	30/05	EQ
Evotec : Update of the Declaration of Conformity with the German Corporate Governance Code for the Year 2023 (May 2024) 127.622 KB	29/05	PU
Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington's disease	29/05	AQ
Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington’s disease	28/05	EQ
Evotec : today announced receipt of a written notice from NASDAQ	27/05	PU
Evotec : Additional Information regarding agenda item 5 (Approval of Remuneration Report)	27/05	PU
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	27/05	EQ
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	27/05	EQ
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	24/05	EQ
Evotec : Letter of the Chair of Supervisory Board to the Shareholders of Evotec	22/05	PU
Evotec : Interim STATEMENT 3M 2024 - Form 6-K	22/05	PU
Evotec reports Q1 2024 results and provides corporate update	22/05	EQ
Evotec : Company Presentation 6.135 MB	21/05	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Evotec SE Other OTC

Actions

EVTCY

US30050E1055

Communiqués

Filtres